Chat with Client Services
Site Search
In September, ARUP Consult, a free informative resource in laboratory testing, released new user experience (UX) upgrades and updated several topics, including acute lymphoblastic leukemia.
ARUP Consult has released several new and updated resources for clinicians, including testing topics on kidney evaluation, gestational trophoblastic disease, and poliovirus.
The CDC recently confirmed the first U.S. case of polio since 2013, which has raised concerns about the virus. New ARUP Consult resources inform clinicians about lab testing for poliovirus.
ARUP’s adoption of a new equation to assess kidney function is a step toward better recognition and diagnosis of chronic kidney disease in populations adversely affected by the previous equation.
ARUP Consult, a free source of expert guidance in laboratory testing, offers valuable information on relevant topics from monkeypox to HLA testing and more.
ARUP has launched a new, in-house test to detect the DNA of orthopoxviruses, including monkeypox.
The Summer 2022 edition of Magnify, now online, features a look at the challenges of autoimmune neurologic testing, our experts in this area, and recent awards, and catches up with a former fellow.
Scientist Michael T. Pyne shares ARUP’s challenges and process of developing a next generation sequencing (NGS) test for HIV-1 antiretroviral drug resistance.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated resources on testing for immunobullous diseases, diabetes mellitus, and prostate cancer.
ARUP offers several antibody panels to test for immunobullous diseases, which are difficult to diagnose. The Immunobullous Disease Testing Comparison tool allows users to quickly compare test options.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new resources on newborn drug screening and noninvasive prenatal testing.
Noninvasive prenatal testing (NIPT) provides critical information to expectant parents. ARUP has updated its test offerings to include the most sensitive and specific alternatives available.
